Stockscreener 앱 받기
4.12
3.00%
0.12
시간 외 거래:
4.20
0.08
+1.94%
전일 마감가:
$4.00
열려 있는:
$4.05
하루 거래량:
2.03M
Relative Volume:
1.09
시가총액:
$710.34M
수익:
$25.55M
순이익/손실:
$-341.97M
주가수익비율:
-1.4714
EPS:
-2.8
순현금흐름:
$-304.44M
1주 성능:
+14.76%
1개월 성능:
+16.71%
6개월 성능:
+21.53%
1년 성능:
-36.52%
1일 변동 폭
$3.855
$4.195
1주일 범위
$3.57
$4.26
52주 변동 폭
$1.775
$10.72
릴레이 테라퓨틱스 Stock (RLAY) Company Profile
명칭
Relay Therapeutics Inc
전화
617-370-8837
주소
60 HAMPSHIRE STREET, CAMBRIDGE
RLAY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RLAY
Relay Therapeutics Inc
|
4.12 | 689.65M | 25.55M | -341.97M | -304.44M | -2.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
릴레이 테라퓨틱스 Stock (RLAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-04 | 재개 | Guggenheim | Buy |
| 2025-04-17 | 개시 | Wells Fargo | Equal Weight |
| 2024-09-10 | 재개 | Goldman | Buy |
| 2024-09-10 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-09-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-05-10 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2023-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2023-04-19 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-04-13 | 개시 | Raymond James | Outperform |
| 2023-02-03 | 개시 | Oppenheimer | Outperform |
| 2022-09-30 | 개시 | Barclays | Equal Weight |
| 2022-09-02 | 개시 | Stifel | Buy |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-02-01 | 개시 | Berenberg | Buy |
| 2021-07-21 | 개시 | BofA Securities | Buy |
| 2020-12-15 | 재확인 | H.C. Wainwright | Buy |
| 2020-12-08 | 개시 | JMP Securities | Mkt Outperform |
| 2020-11-05 | 개시 | H.C. Wainwright | Buy |
| 2020-08-10 | 개시 | Cowen | Outperform |
| 2020-08-10 | 개시 | Goldman | Buy |
| 2020-08-10 | 개시 | Guggenheim | Buy |
| 2020-08-10 | 개시 | JP Morgan | Neutral |
모두보기
릴레이 테라퓨틱스 주식(RLAY)의 최신 뉴스
Will a bounce in Relay Therapeutics Inc. offer an exitMarket Volume Summary & Short-Term Trading Opportunity Alerts - Newser
What’s the profit margin of Relay Therapeutics Inc.July 2025 Macro Moves & Risk Controlled Swing Alerts - خودرو بانک
Is Relay Therapeutics Inc. a defensive stockEarnings Growth Summary & Long-Term Capital Growth Strategies - خودرو بانک
Why Relay Therapeutics Stock Rocketed Nearly 15% Higher This Week - sharewise.com
Relay Therapeutics (RLAY) Stock Rises on Bullish Analyst Note - GuruFocus
Can Relay Therapeutics Inc. expand its profit margins2025 Winners & Losers & Weekly Top Performers Watchlists - خودرو بانک
Tools to assess Relay Therapeutics Inc.’s risk profileEarnings Performance Report & Reliable Breakout Forecasts - Newser
Pattern recognition hints at Relay Therapeutics Inc. upside2025 Key Highlights & Reliable Price Breakout Signals - Newser
What MACD signals say about Relay Therapeutics Inc.Weekly Profit Analysis & Breakout Confirmation Alerts - Newser
Real time breakdown of Relay Therapeutics Inc. stock performance2025 Volume Leaders & Verified Momentum Stock Watchlist - Newser
Predicting Relay Therapeutics Inc. trend using moving averagesMarket Performance Recap & Weekly Stock Performance Updates - Newser
Will Relay Therapeutics Inc. see short term momentumTrade Risk Summary & Long-Term Safe Investment Ideas - Newser
Will Relay Therapeutics Inc. stock hit new highs in YEAR2025 Technical Patterns & AI Forecasted Entry and Exit Points - خودرو بانک
Will Relay Therapeutics Inc. continue its uptrendGlobal Markets & Technical Buy Zone Confirmations - Newser
News impact scoring models applied to Relay Therapeutics Inc.Market Growth Report & Detailed Earnings Play Alerts - Newser
Is Relay Therapeutics Inc. a momentum stock2025 Buyback Activity & AI Powered Market Entry Ideas - خودرو بانک
Momentum divergence signals in Relay Therapeutics Inc. chartWeekly Stock Recap & Consistent Growth Equity Picks - Newser
How moving averages guide Relay Therapeutics Inc. tradingWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - Newser
What does recent volatility data suggest for Relay Therapeutics Inc.2025 Market Overview & Precise Swing Trade Entry Alerts - Newser
Can Relay Therapeutics Inc. hit a new high this monthDip Buying & Risk Controlled Stock Alerts - Newser
Relay Therapeutics Inc. stock daily chart insightsGap Up & Safe Entry Trade Signal Reports - Newser
What candlestick patterns are forming on Relay Therapeutics Inc.CPI Data & Weekly Breakout Watchlists - Newser
Published on: 2025-09-03 06:45:04 - Newser
Kymera Therapeutics Appoints Brian Adams as Chief Legal Officer and Corporate Secretary - GlobeNewswire Inc.
Is Relay Therapeutics Inc. still worth holding after the dip2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Heatmap analysis for Relay Therapeutics Inc. and competitorsJuly 2025 Trade Ideas & Daily Risk Controlled Trade Plans - Newser
Will Relay Therapeutics Inc. price bounce be sustainable2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Will earnings trigger a reversal in Relay Therapeutics Inc.Dollar Strength & High Conviction Investment Ideas - Newser
Comparing Relay Therapeutics Inc. in custom built stock radarsGap Up & Free Expert Approved Momentum Trade Ideas - Newser
Can Relay Therapeutics Inc. sustain its profitability2025 Retail Activity & Stepwise Swing Trade Plans - خودرو بانک
What is the long term forecast for Relay Therapeutics Inc. stockJuly 2025 Update & Growth Oriented Trading Recommendations - خودرو بانک
Volume spikes in Relay Therapeutics Inc. stock – what they meanShare Buyback & Verified Momentum Stock Ideas - Newser
Relay Therapeutics’ SWOT analysis: AI-driven drug discovery stock faces pivotal phase - Investing.com
Bearish Setup: Is Relay Therapeutics Inc. a cyclical or defensive stockJuly 2025 Breakouts & Low Drawdown Investment Strategies - خودرو بانک
릴레이 테라퓨틱스 (RLAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):